Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Cryoport, Inc. before investing.

In this article, we go over a few key elements for understanding Cryoport, Inc.’s stock price such as:

• Cryoport, Inc.’s current stock price and volume
• Why Cryoport, Inc.’s stock price changed recently
• Upgrades and downgrades for CYRX from analysts
• CYRX’s stock price momentum as measured by its relative strength

About Cryoport, Inc. (CYRX)

Before we jump into Cryoport, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company’s Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company’s products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Want to learn more about Cryoport, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Cryoport, Inc..

Cryoport, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Cryoport, Inc.’s stock price was $15.090.

Cryoport, Inc. is down 1.57% from its previous closing price of $15.330.

During the last market session, Cryoport, Inc.’s stock traded between $14.850 and $15.320. Currently, there are approximately 49.90 million shares outstanding for Cryoport, Inc..

Cryoport, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Cryoport, Inc. Stock Price History

Cryoport, Inc.’s (CYRX) price is currently down 3.89% so far this month.

During the month of July, Cryoport, Inc.’s stock price has reached a high of $16.890 and a low of $14.620.

Over the last year, Cryoport, Inc. has hit prices as high as $16.890 and as low as $6.690. Year to date, Cryoport, Inc.’s stock is up 57.19%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Cryoport, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Cryoport, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Cryoport, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Cryoport, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Cryoport, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Cryoport, Inc. (CYRX) by visiting AAII Stock Evaluator.

Relative Price Strength of Cryoport, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Cryoport, Inc. has a weighted four-quarter relative price strength of 20.80%, which translates to a Momentum Score of 93 and is considered to be Very Strong.

Want to learn more about how Cryoport, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Cryoport, Inc. Stock Price: Bottom Line

As of July 31, 2026, Cryoport, Inc.’s stock price is $15.090, which is down 1.57% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Cryoport, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.